Related Experiment Video
Updated: Sep 26, 2025

08:25
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
311
Functional analysis of human circulating immune cells based on high-dimensional mass cytometry
Xiuxing Liu1, Jianjie Lv1, Huishi Wang1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
STAR Protocols
|April 18, 2022
Summary
This study introduces a new mass cytometry workflow to reduce batch effects in clinical immune system analysis. The validated method enhances data reliability for complex blood samples.
Area of Science:
- Immunology
- Biotechnology
- Clinical Diagnostics
Background:
- Mass cytometry offers high-resolution, high-dimensional analysis of complex biological systems like the human immune system.
- Clinical applications of mass cytometry are hindered by batch effects arising from long-term sample collection, potentially masking true biological signals.
- Standardized and validated workflows are crucial for reliable clinical implementation of advanced analytical techniques.
Purpose of the Study:
- To present a validated and streamlined mass cytometry workflow optimized for clinical settings.
- To address and mitigate the issue of batch effects in the analysis of clinical immune samples.
- To enhance the reliability and applicability of mass cytometry in clinical research and diagnostics.
Main Methods:
- Development of a mass cytometry workflow incorporating fixed staining protocols suitable for clinical use.
- Implementation of optimized cellular barcode staining patterns to improve sample multiplexing and data quality.
- Validation of the workflow's efficacy in reducing batch effects and ensuring data consistency.
Main Results:
- The proposed workflow effectively reduces batch effects commonly encountered in long-term clinical sample collection.
- Fixed staining and optimized barcode patterns contribute to more robust and reproducible mass cytometry data.
- The workflow demonstrates improved reliability for analyzing complex immune system profiles in clinical settings.
Conclusions:
- The presented mass cytometry workflow provides a validated solution for overcoming batch effect challenges in clinical sample analysis.
- This streamlined approach extends the practical application range and leverages the full advantages of mass cytometry in clinical research.
- The workflow enhances the potential for accurate immune system profiling and biomarker discovery in clinical settings.

